SIPAI HEALTH (00314) spent HK$1.4467 million on February 5 to repurchase 591,400 shares.
Searainbow Health (00314) announced that on February 5, 2026, they spent HK$1.4467 million to repurchase 591,400 shares.
SIPAI HEALTH (00314) announced on February 5, 2026, that it will spend 1.4467 million Hong Kong dollars to repurchase 591,400 shares.
Related Articles
New stock news | Wuxi Lead Intelligent Equipment (00470) ends its IPO subscription with a total oversubscription of HKD 4.35 billion, 9.1 times the initial offering size.
HK Stock Market Move | JACOBIO-B(01167) rose over 6% in the afternoon; JAB-23E73 global development process is accelerating and GoLayReiSe is expected to rapidly increase volume.
Morgan Stanley: Li & Fung (01113) reported a 4% drop in basic earnings per share last year, with a 2% increase in dividends per share. The target price is HK$47.
New stock news | Wuxi Lead Intelligent Equipment (00470) ends its IPO subscription with a total oversubscription of HKD 4.35 billion, 9.1 times the initial offering size.
HK Stock Market Move | JACOBIO-B(01167) rose over 6% in the afternoon; JAB-23E73 global development process is accelerating and GoLayReiSe is expected to rapidly increase volume.
Morgan Stanley: Li & Fung (01113) reported a 4% drop in basic earnings per share last year, with a 2% increase in dividends per share. The target price is HK$47.
